Tautachrome Recognizes the Emergence of a Trustable Imagery Industry
Aug 07, 2017 11:00 am UTC| Business
ORO VALLEY, Ariz., Aug. 07, 2017 -- Tautachrome, Inc. (OTCQB:TTCM) today announced the appointment of Josh Berger as the new Chief Advancement Officer (CAO), filling the position that has been vacant since the Company’s...
Ducommun Lands New Work for 737-800 Boeing Converted Freighter Program
Aug 07, 2017 11:00 am UTC| Business
SANTA ANA, Calif., Aug. 07, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) has begun work to manufacture aluminum aircraft structures for the Next-Generation 737-800 Boeing Converted Freighter...
Aug 07, 2017 11:00 am UTC| Business
ALAMEDA, Calif., Aug. 07, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests to support the early detection of cancer, announced today that data from the Company’s latest confirmatory...
Humanigen, Inc. Is Effective Today
Aug 07, 2017 11:00 am UTC| Business
BRISBANE, Calif., Aug. 07, 2017 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced that its new name is effective. ...
Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates
Aug 07, 2017 11:00 am UTC| Business
179 Fabry Disease Patients on Reimbursed Galafold (migalastat) as of July 31 – On Target to Reach 300 Patients by Year-End 2017 Migalastat NDA Submission Targeted for 4Q17 Phase 3 EB Topline Data and...
Chimerix Announces Second Quarter 2017 Financial Results
Aug 07, 2017 11:00 am UTC| Business
DURHAM, N.C., Aug. 07, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a corporate update for the...
Aug 07, 2017 11:00 am UTC| Business
HOUSTON, Aug. 07, 2017 -- Oncolix, Inc., a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian cancer, today announced the completion of a merger between Oncolix and a wholly-owned...